GlassScriptPhysician profile
Brenda A Troyer
NPI 1730182098
$651.28
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $171 · 2021: $142 · 2024: $25.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $132.18 | 2019-2020 | |
| Pfizer INC. | $84.42 | 2019-2021 | |
| Abbvie INC. | $79.86 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.63 | 2019-2020 | |
| Avion Pharmaceuticals | $37.79 | 2020 | |
| Ethicon US, LLC | $36.86 | 2019-2021 | |
| Astellas Pharma US INC | $35.32 | 2019-2020 | |
| Allergan, INC. | $35.24 | 2019 | |
| Daiichi Sankyo INC. | $30.69 | 2020 | |
| Merck Sharp & Dohme LLC | $28.51 | 2021 | |
| Biogen, INC. | $25.36 | 2024 | |
| Therapeuticsmd, INC. | $22.41 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $20.46 | 2019 | |
| Myovant Sciences INC. | $19.93 | 2021 | |
| Olympus America INC. | $13.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Troyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.